Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial
The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment. Accurate prediction of SB occlusion after main vessel stenting followed by the use of sp...
Saved in:
Published in | JACC. Cardiovascular interventions Vol. 13; no. 9; p. 1112 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
11.05.2020
|
Subjects | |
Online Access | Get full text |
ISSN | 1876-7605 1876-7605 |
DOI | 10.1016/j.jcin.2020.01.233 |
Cover
Abstract | The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.
Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.
Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.
A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).
An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434). |
---|---|
AbstractList | The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.
Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.
Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.
A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).
An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434). The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.OBJECTIVESThe aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side branch (SB) occlusion in high-risk bifurcation treatment.Accurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.BACKGROUNDAccurate prediction of SB occlusion after main vessel stenting followed by the use of specific strategies to prevent occlusion would be beneficial during bifurcation intervention.Eligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.METHODSEligible patients who had a bifurcation lesions with high risk for occlusion as determined using the validated V-RESOLVE (Visual Estimation for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention) score were randomized to an active SB-P strategy group (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs) or a conventional strategy group (provisional stenting for large SBs and jailed wire technique for small SBs) in a 1:1 ratio stratified by SB vessel size. The primary endpoint of SB occlusion was defined as an angiography core laboratory-assessed decrease in TIMI (Thrombolysis In Myocardial Infarction) flow grade or absence of flow in the SB immediately after full apposition of the main vessel stent to the vessel wall.A total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).RESULTSA total of 335 subjects at 16 sites were randomized to the SB-P group (n = 168) and conventional group (n = 167). Patients in the SB-P versus conventional strategy group had a significantly lower rate of SB occlusion (7.7% [13 of 168] vs. 18.0% [30 of 167]; risk difference: -9.1%; 95% confidence interval: -13.1% to -1.8%; p = 0.006), driven mainly by the difference in the small SB subgroup (jailed balloon technique vs. jailed wire technique: 8.1% vs. 18.5%; p = 0.01).An active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434).CONCLUSIONSAn active SB-P strategy is superior to a conventional strategy in reducing SB occlusion when treating high-risk bifurcation lesions. (Conventional Versus Intentional Strategy in Patients With High Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention [CIT-RESOLVE]; NCT02644434). |
Author | Kirtane, Ajay J Zhang, Dong Zhang, Qi Chen, Shaoliang Pan, Hongwei Dou, Kefei Yang, Yuejin Shen, Zhujun Han, Wei Wang, Yang Liu, Bin Zhao, Yanyan Xu, Bo Guan, Changdong Liu, Jian Li, Yue Zhang, Bin Xie, Lihua Guo, Ning Li, Lang |
Author_xml | – sequence: 1 givenname: Kefei surname: Dou fullname: Dou, Kefei email: drdoukefei@126.com organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China. Electronic address: drdoukefei@126.com – sequence: 2 givenname: Dong surname: Zhang fullname: Zhang, Dong organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China – sequence: 3 givenname: Hongwei surname: Pan fullname: Pan, Hongwei organization: Department of Cardiology, Hunan Provincial People's Hospital, the First Affiliated Hospital of Hunan Normal University, Changsha, China – sequence: 4 givenname: Ning surname: Guo fullname: Guo, Ning organization: Department of Cardiology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China – sequence: 5 givenname: Lang surname: Li fullname: Li, Lang organization: Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China – sequence: 6 givenname: Yue surname: Li fullname: Li, Yue organization: Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, Harbin, China – sequence: 7 givenname: Qi surname: Zhang fullname: Zhang, Qi organization: Department of Cardiology, Shanghai East Hospital, Tongji University, Shanghai, China – sequence: 8 givenname: Bin surname: Liu fullname: Liu, Bin organization: Department of Cardiology, the Second Hospital of Jilin University, Changchun, China – sequence: 9 givenname: Zhujun surname: Shen fullname: Shen, Zhujun organization: Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China – sequence: 10 givenname: Bin surname: Zhang fullname: Zhang, Bin organization: Department of Cardiology, Guangdong General Hospital, Guangzhou, China – sequence: 11 givenname: Jian surname: Liu fullname: Liu, Jian organization: Departments of Cardiology, Peking University People's Hospital, Beijing, China – sequence: 12 givenname: Wei surname: Han fullname: Han, Wei organization: Department of Cardiology, the Third Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, China – sequence: 13 givenname: Yang surname: Wang fullname: Wang, Yang organization: Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China – sequence: 14 givenname: Yanyan surname: Zhao fullname: Zhao, Yanyan organization: Medical Research and Biometrics Center, National Center for Cardiovascular Diseases, Beijing, China – sequence: 15 givenname: Yuejin surname: Yang fullname: Yang, Yuejin organization: State Key Laboratory of Cardiovascular Disease, Beijing, China; Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China – sequence: 16 givenname: Shaoliang surname: Chen fullname: Chen, Shaoliang organization: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China – sequence: 17 givenname: Lihua surname: Xie fullname: Xie, Lihua organization: Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China – sequence: 18 givenname: Changdong surname: Guan fullname: Guan, Changdong organization: Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China – sequence: 19 givenname: Ajay J surname: Kirtane fullname: Kirtane, Ajay J organization: Center for Interventional Vascular Therapy, Columbia University Medical Center/NewYork-Presbyterian Hospital, and the Cardiovascular Research Foundation, New York, New York – sequence: 20 givenname: Bo surname: Xu fullname: Xu, Bo email: bxu@citmd.com organization: National Clinical Research Center for Cardiovascular Diseases, Beijing, China; Catheterization Laboratories, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: bxu@citmd.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32381188$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkM1OwkAcxDcGIx_6Ah7MHr20_ne3n96AoJCQQKBybbbLv7LYdmu3kPg2PotPJkZMPM0k88tkMn3SqUyFhNwycBmw4GHv7pWuXA4cXGAuF-KC9FgUBk4YgN_557ukb-0eIIA45FekK7iIGIuiHimHqtVHpOuRs6QbbOzB0rGpjli12lSyoMO6boxUO9oa2u6QLhvTovoJqcnpVL_unJW2b1-fa71FOmpkpXZoH2lyYsezxFlN1ov5ZkKTRsvimlzmsrB4c9YBeXmaJOOpM188z8bDuVNzxlpHZRxy34tRxSHmkCnJRZ5JEWc5-iEGSniCxQByC56f576KA7b1wxAEQ-F7KAbk_rf3tP39gLZNS20VFoWs0Bxsyj0AX4TCi07o3Rk9ZCVu07rRpWw-0r-LxDf3Bmra |
ContentType | Journal Article |
Copyright | Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
CorporateAuthor | CIT-RESOLVE Investigators |
CorporateAuthor_xml | – name: CIT-RESOLVE Investigators |
DBID | NPM 7X8 |
DOI | 10.1016/j.jcin.2020.01.233 |
DatabaseName | PubMed MEDLINE - Academic |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1876-7605 |
ExternalDocumentID | 32381188 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 0SF 18M 1B1 1P~ 1~. 4.4 457 4G. 53G 5GY 5VS 7-5 8P~ AACTN AAEDW AAFTH AAIKJ AALRI AAOAW AAQFI AAXUO ABBQC ABFRF ABJNI ABMAC ABMZM ABVKL ACGFO ACGFS ADBBV ADEZE ADVLN AEFWE AEKER AEVXI AEXQZ AFCTW AFETI AFJKZ AFRHN AFTJW AGYEJ AITUG AJOXV AJRQY ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ BAWUL BLXMC CS3 DIK EBS F5P FDB FEDTE FNPLU GBLVA HVGLF IXB J1W M41 MO0 N9A NPM O-L O9- OAUVE OA~ OK1 OL0 P-8 P-9 P2P PC. Q38 ROL SDF SEL SES SSZ T5K W8F Z5R 7X8 AAYWO EFKBS EFLBG ~HD |
ID | FETCH-LOGICAL-p211t-cb20f549ec97ef0bca23fba39bfe57e6c3431900ad045ff5c961d577031e354e3 |
ISSN | 1876-7605 |
IngestDate | Sat Sep 27 22:30:44 EDT 2025 Wed Feb 19 02:30:07 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | coronary bifurcation intervention conventional strategy active side branch protection strategy side branch occlusion randomized controlled trial |
Language | English |
License | Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p211t-cb20f549ec97ef0bca23fba39bfe57e6c3431900ad045ff5c961d577031e354e3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
PMID | 32381188 |
PQID | 2400537348 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2400537348 pubmed_primary_32381188 |
PublicationCentury | 2000 |
PublicationDate | 2020-May-11 20200511 |
PublicationDateYYYYMMDD | 2020-05-11 |
PublicationDate_xml | – month: 05 year: 2020 text: 2020-May-11 day: 11 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JACC. Cardiovascular interventions |
PublicationTitleAlternate | JACC Cardiovasc Interv |
PublicationYear | 2020 |
SSID | ssj0060972 |
Score | 2.4139605 |
Snippet | The aim of this study was to determine whether an active side branch protection (SB-P) strategy is superior to the conventional strategy in reducing side... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 1112 |
Title | Active SB-P Versus Conventional Approach to the Protection of High-Risk Side Branches: The CIT-RESOLVE Trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32381188 https://www.proquest.com/docview/2400537348 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1876-7605 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060972 issn: 1876-7605 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect customDbUrl: eissn: 1876-7605 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0060972 issn: 1876-7605 databaseCode: IXB dateStart: 20080201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection 2013 customDbUrl: eissn: 1876-7605 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060972 issn: 1876-7605 databaseCode: .~1 dateStart: 20080201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1876-7605 dateEnd: 20241001 omitProxy: true ssIdentifier: ssj0060972 issn: 1876-7605 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiPcuLxkJcalcJXGc1Ny6pUsXdR9iU9RbFCe26Ao1BRohceGvMxM7mxSKtHCJKstt08zX8Ty-mSHklYy5HBo_ZCr2wUHxuWJZEWUshuPGN0qoPMN4x8lpNJ2H7xdi0ev97LCWqo0a5D921pX8j1RhDeSKVbL_INmrD4UFeA3yhStIGK7XkvGoVlb9i0N23sfAV1UP4GxZ5KN1WzCFBua5bcrgbESkeLAPSC2_WBbIEgAAfLIUuXqa3XHCQDxns4-TfoI_ZsuOHY3HA2SLbJFZO_zJdl59Wdn6H6OXf0Sp35bu4KyTWLUCnMLS93bru6q0gHUbXYAiqHPrToFanQoKl8WRZ5PXesdao4h5B3Cyo1VBHwc71b2NPFwOLvMl9rINPGzBGtjOGtu9tU_P0qP5bJYmk0Xyev2F4dgxTM-7GSw3yM0gjiIcgXG8OGyO8gh7G6HH3tytq7qyBMHfv_TvPkptqyR3yR3nZNCRRcw90tOr--TWiaNRPCCfLXAoAoda4NAucGgDHLopKQCHtsChpaFXwKEIHNoA5w0F2NAObGgNm4dkfjRJxlPmxm6wdeD7G5arwDMilDqXsTYe_FsDblTGpTJaxDrKORid0vOyAtwBY0QuI78QMQ5C0FyEmj8ie6typfcJ5eiNS6lFYbLQcDgc_DguYE8kMqm4PiAvm0eWglrDXFW20mX1LUVqs-DYeumAPLbPMl3b_ispRzPTHw6fXOPdT8ntFpPPyN7ma6Wfgxm5US9qUf8CEKRxLA |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Active+SB-P+Versus+Conventional+Approach+to+the+Protection+of+High-Risk+Side+Branches%3A+The+CIT-RESOLVE+Trial&rft.jtitle=JACC.+Cardiovascular+interventions&rft.au=Dou%2C+Kefei&rft.au=Zhang%2C+Dong&rft.au=Pan%2C+Hongwei&rft.au=Guo%2C+Ning&rft.date=2020-05-11&rft.issn=1876-7605&rft.eissn=1876-7605&rft.volume=13&rft.issue=9&rft.spage=1112&rft_id=info:doi/10.1016%2Fj.jcin.2020.01.233&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1876-7605&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1876-7605&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1876-7605&client=summon |